Neuronal self-injury mediated by IL-1β and MMP-9 in a cerebral palsy model of severe neonatal encephalopathy induced by immune activation plus hypoxia-ischemia

Journal of Neuroinflammation

Guillaume Sébire¹  Djordje Grbic²  Clémence Guiraut²  Mathilde Chevin²  Marie-Elsa Brochu²  Alexandre Savard² 

[1] McGill University, 2300 Tupper street, Montreal, H3H 1P3, QC, Canada;Laboratoire de Neurologie Pédiatrique, Université de Sherbrooke, Sherbrooke, QC, Canada

关键词: Neonatal encephalopathy;    Necroptosis;    Matrix metalloproteinase-9;    Interleukin-1;    Hypoxia-ischemia;    Chemokines;    Cerebral palsy;    Apoptosis;   

Others  :  1227087
DOI  :  10.1186/s12974-015-0330-8

 received in 2014-12-04, accepted in 2015-05-20,  发布年份 2015

【 摘 要 】

Background

Inflammation due to remote pathogen exposure combined to hypoxia/ischemia (HI) is one of the most common causes of neonatal encephalopathy affecting at-term or near-term human newborn, which will consequently develop cerebral palsy. Within term-equivalent rat brains exposed to systemic lipopolysaccharide (LPS) plus HI, it was previously showed that neurons produce IL-1β earlier than do glial cells, and that blocking IL-1 was neuroprotective. To further define the mechanisms whereby IL-1 exerts its neurotoxic effect, we hypothesize that IL-1β plays a pivotal role in a direct and/or indirect mechanistic loop of neuronal self-injury through matrix metalloproteinase (MMP)-9.

Methods

An established preclinical rat model of LPS+HI-induced neonatal encephalopathy was used. In situ hybridization, ELISA, and immunolabeling techniques were employed. Selective blocking compounds allowed addressing the respective roles of IL-1 and MMP-9.

Results

In LPS+HI-exposed forebrains, neuronal IL-1β was first detected in infarcted neocortical and striatal areas and later in glial cells of the adjacent white matter. Neuronal IL-1β played a key role: (i) in the early post-HI exacerbation of neuroinflammation and (ii) in generating both core and penumbral infarcted cerebral areas. Systemically administered IL-1 receptor antagonist (IL-1Ra) reached the brain and bound to the neocortical and deep gray neuronal membranes. Then, IL-1Ra down-regulated IL-1β mRNA and MMP-9 neuronal synthesis. Immediately post-HI, neuronal IL-1β up-regulated cytokine-induced neutrophil chemoattractant (CINC-1), monocyte chemoattractant protein-1 (MCP-1), and inducible nitric oxide synthase. MMP-9 would disrupt the blood–brain barrier, which, combined to CINC-1 up-regulation, would play a role in polymorphonuclear cell (PMN) infiltration into the LPS+HI-exposed brain. IL-1β blockade prevented PMN infiltration and oriented the phenotype of macrophagic/microglial cells towards anti-inflammatory and neurotrophic M2 profile. IL-1β increased the expression of activated caspase-3 and of receptor-interacting-protein (RIP)-3 within infarcted forebrain area. Such apoptotic and necroptotic pathway activations were prevented by IL-1Ra, as well as ensuing cerebral palsy-like brain damage and motor impairment.

Conclusions

This work uncovered a new paradigm of neuronal self-injury orchestrated by neuronal synthesis of IL-1β and MMP-9. In addition, it reinforced the translational neuroprotective potential of IL-1 blockers to alleviate human perinatal brain injuries.

【 授权许可】

   
2015 Savard et al.; licensee BioMed Central.

【 图 表 】

Fig. 1.

Fig. 2.

Fig. 3.

Fig. 4.

Fig. 5.

Fig. 6.

Fig. 7.

Fig. 8.

Fig. 9.

Fig. 10.

【 参考文献 】

• [1]Grether JK, Nelson KB: Maternal infection and cerebral palsy in infants of normal birth weight. JAMA 1997, 278:207-11.
• [2]Wintermark P, Boyd T, Gregas MC, Labrecque M, Hansen A: Placental pathology in asphyxiated newborns meeting the criteria for therapeutic hypothermia. Am J Obstet Gynecol 2010, 203:579.
• [3]Chau V, Poskitt KJ, McFadden DE, Bowen-Roberts T, Synnes A, Brant R, et al.: Effect of chorioamnionitis on brain development and injury in premature newborns. Ann Neurol 2009, 66:155-64.
• [4]Patel SD, Pierce L, Ciardiello AJ, Vannucci SJ: Neonatal encephalopathy: pre-clinical studies in neuroprotection. Biochem Soc Trans 2014, 42:564-8.
• [5]Girard S, Kadhim H, Beaudet N, Sarret P, Sebire G: Developmental motor deficits induced by combined fetal exposure to lipopolysaccharide and early neonatal hypoxia/ischemia: a novel animal model for cerebral palsy in very premature infants. Neuroscience 2009, 158:673-82.
• [6]Ferriero DM: Neonatal brain injury. N Engl J Med 2004, 351:1985-95.
• [7]Volpe JJ: Brain injury in premature infants: a complex amalgam of destructive and developmental disturbances. Lancet Neurol 2009, 8:110-24.
• [8]Aden U, Favrais G, Plaisant F, Winerdal M, Felderhoff-Mueser U, Lampa J, et al.: Systemic inflammation sensitizes the neonatal brain to excitotoxicity through a pro-/anti-inflammatory imbalance: key role of TNFalpha pathway and protection by etanercept. Brain Behav Immun 2010, 24:747-58.
• [9]Eklind S, Mallard C, Leverin AL, Gilland E, Blomgren K, Mattsby-Baltzer I, et al.: Bacterial endotoxin sensitizes the immature brain to hypoxic–ischaemic injury. Eur J Neurosci 2001, 13:1101-6.
• [10]Coumans AB, Middelanis JS, Garnier Y, Vaihinger HM, Leib SL, Von Duering MU, et al.: Intracisternal application of endotoxin enhances the susceptibility to subsequent hypoxic-ischemic brain damage in neonatal rats. Pediatr Res 2003, 53:770-5.
• [11]Wang X, Stridh L, Li W, Dean J, Elmgren A, Gan L, et al.: Lipopolysaccharide sensitizes neonatal hypoxic-ischemic brain injury in a MyD88-dependent manner. J Immunol 2009, 183:7471-7.
• [12]Larouche A, Roy M, Kadhim H, Tsanaclis AM, Fortin D, Sebire G: Neuronal injuries induced by perinatal hypoxic-ischemic insults are potentiated by prenatal exposure to lipopolysaccharide: animal model for perinatally acquired encephalopathy. Dev Neurosci 2005, 27:134-42.
• [13]Towfighi J, Mauger D, Vannucci RC, Vannucci SJ: Influence of age on the cerebral lesions in an immature rat model of cerebral hypoxia-ischemia: a light microscopic study. Brain Res Dev Brain Res 1997, 100:149-60.
• [14]Brochu ME, Girard S, Lavoie K, Sebire G: Developmental regulation of the neuroinflammatory responses to LPS and/or hypoxia-ischemia between preterm and term neonates: an experimental study. J Neuroinflammation 2011, 8:55. BioMed Central Full Text
• [15]Savard A, Lavoie K, Brochu ME, Grbic D, Lepage M, Gris D, et al.: Involvement of neuronal IL-1beta in acquired brain lesions in a rat model of neonatal encephalopathy. J Neuroinflammation 2013, 10:110. BioMed Central Full Text
• [16]Relton JK, Martin D, Thompson RC, Russell DA: Peripheral administration of interleukin-1 receptor antagonist inhibits brain damage after focal cerebral ischemia in the rat. Exp Neurol 1996, 138:206-13.
• [17]Lalancette-Hebert M, Gowing G, Simard A, Weng YC, Kriz J: Selective ablation of proliferating microglial cells exacerbates ischemic injury in the brain. J Neurosci 2007, 27:2596-605.
• [18]Borlongan CV, Cahill DW, Sanberg PR: Locomotor and passive avoidance deficits following occlusion of the middle cerebral artery. Physiol Behav 1995, 58:909-17.
• [19]Chu K, Kim M, Park KI, Jeong SW, Park HK, Jung KH, et al.: Human neural stem cells improve sensorimotor deficits in the adult rat brain with experimental focal ischemia. Brain Res 2004, 1016:145-53.
• [20]Schroder K, Tschopp J: The inflammasomes. Cell 2010, 140:821-32.
• [21]Kigerl KA, Gensel JC, Ankeny DP, Alexander JK, Donnelly DJ, Popovich PG: Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J Neurosci 2009, 29:13435-44.
• [22]Liu F, McCullough LD: Inflammatory responses in hypoxic ischemic encephalopathy. Acta Pharmacol Sin 2013, 34:1121-30.
• [23]Svedin P, Hagberg H, Savman K, Zhu C, Mallard C: Matrix metalloproteinase-9 gene knock-out protects the immature brain after cerebral hypoxia-ischemia. J Neurosci 2007, 27:1511-8.
• [24]Jiang Z, Li C, Arrick DM, Yang S, Baluna AE, Sun H: Role of nitric oxide synthases in early blood–brain barrier disruption following transient focal cerebral ischemia. PLoS One 2014., 9Article ID e93134
• [25]Allan SM, Tyrrell PJ, Rothwell NJ: Interleukin-1 and neuronal injury. Nat Rev Immunol 2005, 5:629-40.
• [26]Tchelingerian JL, Le Saux F, Jacque C: Identification and topography of neuronal cell populations expressing TNF alpha and IL-1 alpha in response to hippocampal lesion. J Neurosci Res 1996, 43:99-106.
• [27]Kadhim H, Tabarki B, De Prez C, Sebire G: Cytokine immunoreactivity in cortical and subcortical neurons in periventricular leukomalacia: are cytokines implicated in neuronal dysfunction in cerebral palsy? Acta Neuropathol 2003, 105:209-16.
• [28]Sairanen TR, Lindsberg PJ, Brenner M, Siren AL: Global forebrain ischemia results in differential cellular expression of interleukin-1beta (IL-1beta) and its receptor at mRNA and protein level. J Cereb Blood Flow Metab 1997, 17:1107-20.
• [29]Degos V, Peineau S, Nijboer C, Kaindl AM, Sigaut S, Favrais G, et al.: G protein-coupled receptor kinase 2 and group I metabotropic glutamate receptors mediate inflammation-induced sensitization to excitotoxic neurodegeneration. Ann Neurol 2013, 73:667-78.
• [30]Martinez FO, Sica A, Mantovani A, Locati M: Macrophage activation and polarization. Front Biosci 2008, 13:453-61.
• [31]Valentijn AJ, Zouq N, Gilmore AP: Anoikis. Biochem Soc Trans 2004, 32:421-5.
• [32]Danjo S, Ishihara Y, Watanabe M, Nakamura Y, Itoh K: Pentylentetrazole-induced loss of blood–brain barrier integrity involves excess nitric oxide generation by neuronal nitric oxide synthase. Brain Res 2013, 1530:44-53.
• [33]Kaiser WJ, Upton JW, Mocarski ES: Viral modulation of programmed necrosis. Curr Opin Virol 2013, 3:296-306.
• [34]Yager J, Towfighi J, Vannucci RC: Influence of mild hypothermia on hypoxic-ischemic brain damage in the immature rat. Pediatr Res 1993, 34:525-9.
• [35]Azzopardi D, Strohm B, Marlow N, Brocklehurst P, Deierl A, Eddama O, et al.: Effects of hypothermia for perinatal asphyxia on childhood outcomes. N Engl J Med 2014, 371:140-9.